Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics

Launched by HACETTEPE UNIVERSITY · Jan 22, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how asthma affects people in different ways, specifically looking at two types of asthma: allergic asthma and eosinophilic asthma. Researchers want to understand the level of breathing difficulties, symptoms, and overall health (or frailty) in patients with these types of asthma. By gathering this information, they hope to develop better treatment and rehabilitation strategies tailored to each type of asthma, helping healthcare providers offer more effective care.

To participate in the study, you should be between 35 and 75 years old and have been diagnosed with either allergic or eosinophilic asthma. However, people with certain conditions, like cognitive impairment or recent severe asthma attacks, will not be eligible. If you join the trial, you can expect to undergo assessments that will help researchers learn more about how your asthma affects your daily life and well-being. This study is currently looking for participants, and your involvement could contribute to improving asthma care for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 35-75 years,
• • Diagnosed with allergic or eosonophilic asthma according to the Global Strategy for the Prevention and Treatment of Asthma (GINA).
• Exclusion Criteria:
• • Known cognitive impairment,
• • Having had an acute asthma attack in the last 6 weeks,
• • Having changed medication in the last 4 weeks.